论文部分内容阅读
胃镜检查术前,为便于手术中对胃、十二指肠观察,多采用阿托品0.5～1mg皮下注射,以抑制胃肠蠕动,减少恶心及胃液分泌.但阿托品可引起心动过速、视物模糊、口干、皮肤潮红、眼压增高及排尿障碍等副作用,青光眼、前列腺肥大等受检者,如病史询问不详,有诱发或加重病情可能。为此,我们采用舌下含化硝苯吡啶(N法)代替阿托品(A法)检查600照观察40例结果报道如下. 材料与方法 N法组40例中男31例,女9例;年龄21～59岁,平均37.2岁.病种计各种胃炎19例,十二指肠炎7例,消化性溃疡7例,食道炎1例,胃十二指肠正常者8例.A法组40例中男28例,女12例;
Gastroscopy before surgery, in order to facilitate the operation of the stomach, duodenum observation, more use of atropine 0.5 ~ 1mg subcutaneous injection to inhibit gastrointestinal motility, reduce nausea and gastric secretion, but atropine can cause tachycardia, blurred vision , Dry mouth, skin flushing, intraocular pressure and voiding dysfunction and other side effects, glaucoma, prostatic hypertrophy and other subjects, such as medical history is unknown, there may be induced or aggravate the disease. To this end, we use the sublingual nifedipine (N method) instead of atropine (A method) check 600 according to the observation of 40 cases reported as follows.Materials and Methods N method group 40 cases of male and 31 males and 9 females; age 21 to 59 years old, with an average of 37.2 years old .In 19 cases of various gastritis, 7 cases of duodenitis, 7 cases of peptic ulcer, 1 case of esophagitis, 8 cases of normal gastroduodenal .A group 40 Cases of male 28 cases, 12 females;